From Science to Scale: Crossing the Hype Chasm with Industrialized GMP AI in API and Drug Manufacturing

Adopting AI in a CDMO environment is not just a technological decision; it’s a scientific, engineering, and regulatory challenge. In this session, we’ll demystify what AI truly means for pharmaceutical manufacturing and uncover why one-size-fits-all models fall short. You’ll learn why each product and equipment combination often requires dedicated models, and what it takes to scale and monitor them effectively within GxP constraints. We’ll explore how cloud-based platforms enable industrialisation of AI while meeting strict regulatory requirements. Finally, a real-world case study will showcase how GxP-compliant AI was successfully scaled to improve yield and accelerate batch release.

Join us to understand the real hurdles CDMOs face and how to overcome them.